Daito Pharmaceutical Co (TSE:4577) Other Stockholders Equity: 円1,585 Mil (As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4577 Daito Pharmaceutical Co Ltd TSE:4577
73 GF Score
Price 円1,309.00
GF Value 円1,278.05
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Daito Pharmaceutical Co Other Stockholders Equity?

Daito Pharmaceutical Co TSE:4577 +0.69% 73 Other Stockholders Equity is 円1,585 Mil as of Feb. 2026. GuruFocus rates TSE:4577 with a GF Score™ of 73/100 and a GF Value™ of 円1,278.05 (Fairly Valued). The stock has 3 warning signs investors should review.

Daito Pharmaceutical Co's Other Stockholders Equity for the quarter that ended in Feb. 2026 was 円1,585 Mil.

Daito Pharmaceutical Co's quarterly Other Stockholders Equity increased from Aug. 2025 (円1,313 Mil) to Nov. 2025 (円1,376 Mil) and increased from Nov. 2025 (円1,376 Mil) to Feb. 2026 (円1,585 Mil).

Daito Pharmaceutical Co's annual Other Stockholders Equity declined from May. 2024 (円1,713 Mil) to May. 2025 (円1,315 Mil) but then increased from May. 2025 (円1,315 Mil) to May. 2026 (円1,791 Mil).

Daito Pharmaceutical Co Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Daito Pharmaceutical Co's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Daito Pharmaceutical Co Other Stockholders Equity Chart

Daito Pharmaceutical Co Annual Data
Trend May17 May18 May19 May20 May21 May22 May23 May24 May25 May26
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,031.00 1,532.00 1,713.00 1,315.00 1,791.00

Daito Pharmaceutical Co Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,315.00 1,313.00 1,376.00 1,585.00 1,791.00
TSE:4577
73GF Score
Daito Pharmaceutical Co Ltd TSE:4577
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Daito Pharmaceutical Co Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of 円1,585 Mil mean?
Daito Pharmaceutical Co (TSE:4577) has a Other Stockholders Equity of 円1,585 Mil as of Feb. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Daito Pharmaceutical Co and its competitors.
Is Daito Pharmaceutical Co's Other Stockholders Equity too high?
Daito Pharmaceutical Co's current Other Stockholders Equity is 円1,585 Mil. Overall, Daito Pharmaceutical Co has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Daito Pharmaceutical Co's Other Stockholders Equity compare to ZTS and UTHR?
Daito Pharmaceutical Co's Other Stockholders Equity of 円1,585 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Drug Manufacturers company?
A good Other Stockholders Equity depends on the Drug Manufacturers industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Daito Pharmaceutical Co and its competitors. Daito Pharmaceutical Co's current Other Stockholders Equity is 円1,585 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daito Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Daito Pharmaceutical Co (TSE:4577) is currently considered Fairly Valued. The stock's GF Value™ is 円1,278.05, compared to a current price of 円1,309.00 — trading 2.4% above its estimated fair value. The current Other Stockholders Equity is 円1,585 Mil. Daito Pharmaceutical Co's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Daito Pharmaceutical Co (TSE:4577), the current Other Stockholders Equity is 円1,585 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Daito Pharmaceutical Co (TSE:4577) Overvalued in 2026?

Based on GuruFocus' analysis, Daito Pharmaceutical Co stock appears to be overvalued. The current stock price of 円1,309.00 is trading 2.4% above its estimated GF Value™ of 円1,278.05. GuruFocus considers Daito Pharmaceutical Co to be Fairly Valued.

Key valuation signals for TSE:4577:

  • Other Stockholders Equity: 円1,585 Mil
  • GF Value™: 円1,278.05 vs. price of 円1,309.00 (2.4% above fair value)
  • GF Score™: 73/100 with 3 warning signs

No single metric tells the full story. See the TSE:4577 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Daito Pharmaceutical Co Business Description

Address 326 Yokamachi, Toyama, JPN, 939-8567
Daito Pharmaceutical Co Ltd is engaged in the research and development of pharmaceutical products. The company also undertakes contract manufacturing.
73GF Score

Get the complete analysis for TSE:4577

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,309.00
Price
円1,278.05
GF Value